Skip to content
  • Sunday, 26 July 2026
  • 1:47 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Canada’s Drug Agency Data Reveals Evolving Landscape of Drug Approvals and Reimbursement
Pharmaceutical R&D

Canada’s Drug Agency Data Reveals Evolving Landscape of Drug Approvals and Reimbursement

Teuku Ryan Jun 14, 2026 0

In April 2026, Canada’s Drug Agency (CDA) unveiled an expanded dataset, offering a comprehensive look at the trends and intricacies…

Read More
Pharmaceutical R&D

New Qulipta Study Data Bolsters Case Against Restrictive European Reimbursement Policies

Teuku Ryan Apr 25, 2026 0

New clinical trial results presented by AbbVie are poised to significantly influence the landscape of migraine prevention in Europe, providing…

Read More
Clinical Diagnostics & Pathology

Executive War College 2026 Speaker Spotlight Illuminates Path for Labs Navigating Reimbursement Pressures and Regulatory Shifts

Reynand Amr Wu Mar 18, 2026 0

The 2026 Executive War College on Diagnostics, Clinical Laboratory, and Pathology Management, scheduled for April 28-29 in New Orleans, is…

Read More
CEPI Fast-Tracks Ebola Vaccine Candidates from IAVI, Moderna and OxfordLeveraging Mimesis for Secure Data Science: A Comprehensive Guide to Anonymizing Production Data.Breakthrough Discovery at Tokyo Metropolitan University Explains the Hidden Mechanics of Foam Drainage and Bubble RearrangementProfessor Albert Heck Honored with John B. Fenn Award for Transformative Contributions to Biomolecular Mass Spectrometry
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ